GlassScriptPhysician profile
Beth A Steinmetz
NPI 1730675216
$1,297.33
in general payments reported to CMS, 2019-2025
19 companies · $832 in 2025
The $832 reported for 2025 was more than what 82% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $67.04 · 2023: $135 · 2024: $263 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,230.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $807.46 | 2022-2025 | |
| Lundbeck LLC | $98.13 | 2024-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $70.85 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.23 | 2025 | Caplyta |
| Pfizer INC. | $36.15 | 2025 | |
| Sumitomo Pharma America, INC. | $30.87 | 2024 | Gemtesa |
| Glaxosmithkline, LLC. | $25.68 | 2025 | Shingrix |
| Ironshore Pharmaceuticals INC. | $23.20 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $21.20 | 2025 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $17.32 | 2024 | |
| Krystal Biotech INC | $17.32 | 2025 | Vyjuvek |
| Janssen Pharmaceuticals, INC | $16.31 | 2024 | Spravato |
| Novo Nordisk INC | $16.10 | 2024 | Rybelsus, Ozempic |
| Amgen INC. | $14.35 | 2025 | Repatha, Otezla |
| Antares Pharma, INC. | $14.17 | 2025 | Xyosted |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $13.33 | 2023 | Dupixent |
| Merck Sharp & Dohme LLC | $13.06 | 2023 | Dificid |
| Daiichi Sankyo INC. | $12.53 | 2022 | |
| Janssen Biotech, INC. | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Steinmetz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.